259 related articles for article (PubMed ID: 10931446)
1. Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma.
Dohchin A; Suzuki JI; Seki H; Masutani M; Shiroto H; Kawakami Y
Cancer; 2000 Aug; 89(3):482-7. PubMed ID: 10931446
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin.
Saleh Y; Siewiński M; Kielan W; Ziółkowski P; Gryboś M; Rybka J
J Exp Ther Oncol; 2003; 3(6):319-24. PubMed ID: 14678520
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings.
Watanabe M; Higashi T; Watanabe A; Osawa T; Sato Y; Kimura Y; Tominaga S; Hashimoto N; Yoshida Y; Morimoto S
Biochem Med Metab Biol; 1989 Aug; 42(1):21-9. PubMed ID: 2775560
[TBL] [Abstract][Full Text] [Related]
4. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
5. [Role and behavior of cathepsin B and cathepsin L in gastric cancer].
Herszényi L; Plebani M; Carraro P; De Paoli M; Roveroni G; Rugge M; Cardin R; Naccarato R; Farinati F
Orv Hetil; 1995 Jun; 136(25):1315-8. PubMed ID: 7596589
[TBL] [Abstract][Full Text] [Related]
6. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
Fröhlich E; Möhrle M; Klessen C
Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer.
Thomssen C; Schmitt M; Goretzki L; Oppelt P; Pache L; Dettmar P; Jänicke F; Graeff H
Clin Cancer Res; 1995 Jul; 1(7):741-6. PubMed ID: 9816040
[TBL] [Abstract][Full Text] [Related]
8. Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC).
Lah TT; Calaf G; Kalman E; Shinde BG; Russo J; Jarosz D; Zabrecky J; Somers R; Daskal I
Biol Chem Hoppe Seyler; 1995 Jun; 376(6):357-63. PubMed ID: 7576229
[TBL] [Abstract][Full Text] [Related]
9. Elevation of tissue cathepsin B and L activities in gastric cancer.
Watanabe M; Higashi T; Hashimoto M; Tomoda I; Tominaga S; Hashimoto N; Morimoto S; Yamauchi Y; Nakatsukasa H; Kobayashi M
Hepatogastroenterology; 1987 Jun; 34(3):120-2. PubMed ID: 3610018
[TBL] [Abstract][Full Text] [Related]
10. Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer.
Vigneswaran N; Zhao W; Dassanayake A; Muller S; Miller DM; Zacharias W
Hum Pathol; 2000 Aug; 31(8):931-7. PubMed ID: 10987253
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin expression in oral squamous cell carcinoma: relationship with clinicopathologic factors.
Kawasaki G; Kato Y; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Apr; 93(4):446-54. PubMed ID: 12029284
[TBL] [Abstract][Full Text] [Related]
12. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells.
Colella R; Casey SF
Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846
[TBL] [Abstract][Full Text] [Related]
13. Cysteine and serine proteases in gastric cancer.
Plebani M; Herszènyi L; Cardin R; Roveroni G; Carraro P; Paoli MD; Rugge M; Grigioni WF; Nitti D; Naccarato R
Cancer; 1995 Aug; 76(3):367-75. PubMed ID: 8625115
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis.
Farinati F; Herszényi L; Plebani M; Carraro P; De Paoli M; Cardin R; Roveroni G; Rugge M; Nitti D; Grigioni WF; D'Errico A; Naccarato R
Carcinogenesis; 1996 Dec; 17(12):2581-7. PubMed ID: 9006092
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis and lysosomal cathepsins B and L in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance.
Russo A; Bazan V; Gebbia N; Pizzolanti G; Tumminello FM; Dardanoni G; Ingria F; Restivo S; Tomasino RM; Leto G
Cancer; 1995 Nov; 76(10):1757-64. PubMed ID: 8625044
[TBL] [Abstract][Full Text] [Related]
17. Cysteine protease activities and tumor development in human colorectal carcinoma.
Sheahan K; Shuja S; Murnane MJ
Cancer Res; 1989 Jul; 49(14):3809-14. PubMed ID: 2544258
[TBL] [Abstract][Full Text] [Related]
18. Matrigel invasion by the prostate cancer cell lines, PC3 and DU145, and cathepsin L+B activity.
Colella R; Jackson T; Goodwyn E
Biotech Histochem; 2004; 79(3-4):121-7. PubMed ID: 15621884
[TBL] [Abstract][Full Text] [Related]
19. Expression of Cathepsin B and L antigen and activity is associated with early colorectal cancer progression.
Troy AM; Sheahan K; Mulcahy HE; Duffy MJ; Hyland JM; O'Donoghue DP
Eur J Cancer; 2004 Jul; 40(10):1610-6. PubMed ID: 15196548
[TBL] [Abstract][Full Text] [Related]
20. Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance.
Xu X; Yuan G; Liu W; Zhang Y; Chen W
Exp Oncol; 2009 Jun; 31(2):102-5. PubMed ID: 19550400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]